Cargando…

Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry

AIMS: Dilated cardiomyopathy (DCM) is a complex disease where genetics interplay with extrinsic factors. This study aims to compare the phenotype, management, and outcome of familial DCM (FDCM) and non‐familial (sporadic) DCM (SDCM) across Europe. METHODS AND RESULTS: Patients with DCM that were enr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Asselbergs, Folkert W., Sammani, Arjan, Elliott, Perry, Gimeno, Juan R., Tavazzi, Luigi, Tendera, Michael, Kaski, Juan Pablo, Maggioni, Aldo P., Rubis, Pawel P., Jurcut, Ruxandra, Heliö, Tiina, Calò, Leonardo, Sinagra, Gianfranco, Zdravkovic, Marija, Olivotto, Iacopo, Kavoliūnienė, Aušra, Laroche, Cécile, Caforio, Alida L.P., Charron, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835585/ https://www.ncbi.nlm.nih.gov/pubmed/33179448 http://dx.doi.org/10.1002/ehf2.13100

Ejemplares similares

ESC EORP Cardiomyopathy Registry: real‐life practice of genetic counselling and testing in adult cardiomyopathy patients
por: Heliö, Tiina, et al.
Publicado: (2020)

Current use of cardiac magnetic resonance in tertiary referral centres for the diagnosis of cardiomyopathy: the ESC EORP Cardiomyopathy/Myocarditis Registry
por: Mizia-Stec, Katarzyna, et al.
Publicado: (2021)

Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry
por: Lopes, Luis R, et al.
Publicado: (2022)

Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM Registry
por: Jackson, Alice M., et al.
Publicado: (2021)

Electrocardiographic features and their echocardiographic correlates in peripartum cardiomyopathy: results from the ESC EORP PPCM registry
por: Mbakwem, Amam C., et al.
Publicado: (2021)

Corrigendum to: Current use of cardiac magnetic resonance in tertiary referral centres for the diagnosis of cardiomyopathy: the ESC EORP Cardiomyopathy/Myocarditis Registry
Publicado: (2021)

Atrial fibrillation, anticoagulation management and risk of stroke in the Cardiomyopathy/Myocarditis registry of the EURObservational Research Programme of the European Society of Cardiology
por: Mizia‐Stec, Katarzyna, et al.
Publicado: (2020)

AFA-Recur: an ESC EORP AFA-LT registry machine-learning web calculator predicting atrial fibrillation recurrence after ablation
por: Saglietto, Andrea, et al.
Publicado: (2022)

Hypertensive disorders of pregnant women with heart disease: the ESC EORP ROPAC Registry( )
por: Ramlakhan, Karishma P, et al.
Publicado: (2022)

Outcomes of culture-negative vs. culture-positive infective endocarditis: the ESC-EORP EURO-ENDO registry
por: Kong, William K F, et al.
Publicado: (2022)

Adenosine usage during AF ablation in Europe and selected long-term findings from the ESC-EHRA EORP Atrial Fibrillation Ablation Long-Term registry
por: van Rosmalen, Frank, et al.
Publicado: (2020)

Cardiac device-related infective endocarditis need for lead extraction whatever the device according to the ESC EORP EURO-ENDO registry
por: Donal, Erwan, et al.
Publicado: (2023)

Pregnancy outcomes in women with a systemic right ventricle and transposition of the great arteries results from the ESC-EORP Registry of Pregnancy and Cardiac disease (ROPAC)
por: Tutarel, Oktay, et al.
Publicado: (2022)

Infective endocarditis in the Netherlands: current epidemiological profile and mortality: An analysis based on partial ESC EORP collected data
por: El Kadi, S., et al.
Publicado: (2020)

Impact of renal impairment on atrial fibrillation: ESC‐EHRA EORP‐AF Long‐Term General Registry
por: Ding, Wern Yew, et al.
Publicado: (2022)

Corrigendum to: Outcomes of culture-negative vs. culture-positive infective endocarditis: the ESC-EORP EURO-ENDO registry
Publicado: (2023)

Editorial: Paediatric Cardiomyopathies
por: Monda, Emanuele, et al.
Publicado: (2021)

Diagnosis and Risk Prediction of Dilated Cardiomyopathy in the Era of Big Data and Genomics
por: Sammani, Arjan, et al.
Publicado: (2021)

Childhood Hypertrophic Cardiomyopathy: A Disease of the Cardiac Sarcomere
por: Norrish, Gabrielle, et al.
Publicado: (2021)

Risk stratification in childhood hypertrophic cardiomyopathy
por: Norrish, Gabrielle, et al.
Publicado: (2018)

Report on the 2nd Florence International Symposium on Advances in Cardiomyopathies: 9th meeting of the European Myocardial and Pericardial Diseases WG of the ESC
por: Cecchi, Franco, et al.
Publicado: (2013)

Characteristics, management, and outcomes of patients with left‐sided infective endocarditis complicated by heart failure: a substudy of the ESC‐EORP EURO‐ENDO (European infective endocarditis) registry
por: Bohbot, Yohann, et al.
Publicado: (2022)

Participation in a clinical trial is associated with lower mortality but not lower risk of HF hospitalization in patients with heart failure: observations from the ESC EORP Heart Failure Long-Term Registry
por: Kapelios, Chris J, et al.
Publicado: (2023)

Editorial: Cardiovascular genetics—focus on paediatric cardiomyopathy
por: Monda, Emanuele, et al.
Publicado: (2023)

New ESC guidelines on hypertrophic cardiomyopathy: new insights in invasive treatment?
por: van der Wall, E. E.
Publicado: (2014)

Life-long tailoring of management for patients with hypertrophic cardiomyopathy: Awareness and decision-making in changing scenarios
por: Michels, M., et al.
Publicado: (2016)

Impact of Demographic Features, Lifestyle, and Comorbidities on the Clinical Expression of Hypertrophic Cardiomyopathy
por: Finocchiaro, Gherardo, et al.
Publicado: (2017)

Sclerodermic Cardiomyopathy—A State-of-the-Art Review
por: Giucă, Adrian, et al.
Publicado: (2022)

Clinical and molecular classification of cardiomyopathies
por: Cecchi, Franco, et al.
Publicado: (2012)

Quality of life status determinants in hypertrophic cardiomyopathy as evaluated by the Kansas City Cardiomyopathy Questionnaire
por: Capota, Razvan, et al.
Publicado: (2020)

DCM-PROGRESS: predicting end-stage heart failure in non-ischemic dilated cardiomyopathy patients
por: Schmidt, A F, et al.
Publicado: (2023)

Dilated cardiomyopathy
por: Schultheiss, Heinz-Peter, et al.
Publicado: (2019)

Microvascular Dysfunction in Hypertrophic Cardiomyopathy
por: Pelliccia, Francesco, et al.
Publicado: (2022)

Clinical and Genetic Screening for Hypertrophic Cardiomyopathy in Paediatric Relatives: Changing Paradigms in Clinical Practice
por: Lawley, Claire M., et al.
Publicado: (2023)

Predicting sustained ventricular arrhythmias in dilated cardiomyopathy: a meta‐analysis and systematic review
por: Sammani, Arjan, et al.
Publicado: (2020)

Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveys
por: Ferrannini, Giulia, et al.
Publicado: (2021)

Dilated Cardiomyopathy: A Paradigm of Revolution in Medicine
por: Merlo, Marco, et al.
Publicado: (2020)

The innate immune system in chronic cardiomyopathy: a European Society of Cardiology (ESC) scientific statement from the Working Group on Myocardial Function of the ESC
por: Frantz, Stefan, et al.
Publicado: (2018)

Risk stratification in cardiomyopathy
por: Sinagra, Gianfranco, et al.
Publicado: (2020)

Echocardiographic Advances in Dilated Cardiomyopathy
por: Faggiano, Andrea, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c91i3m1tdncusp9sbkrkjcg9ta